Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emotional behavior altered after multiple exposures to anesthesia during infancy

  • Smallest 3-D camera offers brain surgery innovation

  • Study shows how investments reflected shift in environmental views

  • Who gets a transplant organ?

  • Long-term study links common psychiatric disorders with increased risk of violent reoffending in ex-prisoners

  • Do antipsychotic medications affect cortical thinning?

  • Diabetes and brain tangles may be linked independently of Alzheimer's disease

  • Neuron responsible for alcoholism found

  • Reward, aversion behaviors activated through same brain pathways

  • Hiring more minority teachers in schools gives fairer perception of discipline

  •